AGR2 Predicts Tamoxifen Resistance in Postmenopausal Breast Cancer Patients

Endocrine resistance is a significant problem in breast cancer treatment. Thus identification and validation of novel resistance determinants is important to improve treatment efficacy and patient outcome. In our work, AGR2 expression was determined by qRT-PCR in Tru-Cut needle biopsies from tamoxif...

Descripció completa

Guardat en:
Dades bibliogràfiques
Autors principals: Hrstka, Roman, Brychtova, Veronika, Fabian, Pavel, Vojtesek, Borivoj, Svoboda, Marek
Format: Artigo
Idioma:Inglês
Publicat: Hindawi Publishing Corporation 2013
Matèries:
Clinical Study
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC3776368/
https://ncbi.nlm.nih.gov/pubmed/24167368
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2013/761537
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars